{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T04:08:17Z","timestamp":1792382897523,"version":"4.4.0"},"reference-count":241,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.cytogfr.2004.06.004","type":"journal-article","created":{"date-parts":[[2004,10,5]],"date-time":"2004-10-05T15:36:57Z","timestamp":1096990617000},"page":"457-475","source":"Crossref","is-referenced-by-count":567,"title":["The molecular triad OPG\/RANK\/RANKL: involvement in the orchestration of pathophysiological bone remodeling"],"prefix":"10.1016","volume":"15","author":[{"given":"Sandrine","family":"Theoleyre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohann","family":"Wittrant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steeve Kwan","family":"Tat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Fortun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francoise","family":"Redini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Heymann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2004.06.004_bib1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cytogfr.2003.10.005","article-title":"IL-6, RANKL, TNF-alpha\/IL-1: interrelations in bone resorption pathophysiology","volume":"15","author":"Kwan Tat","year":"2004","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cytogfr.2004.06.004_bib2","first-page":"59","article-title":"Mesenchymal stem cells and osteoblast differentiation","volume":"vol. 1","author":"Aubin","year":"2002"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S8756-3282(02)00672-5","article-title":"Osteoclastic acidication during bone resorption","volume":"30","author":"Rousselle","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/00220345650440012801","article-title":"Correlation of bone resorption and formation with the physical behaviour of loaded bone","volume":"44","author":"Epker","year":"1965","journal-title":"J Dent Res"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib5","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1006\/cyto.2000.0747","article-title":"gp130 cytokine family and bone cells","volume":"12","author":"Heymann","year":"2000","journal-title":"Cytokine"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib6","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1210\/endo-123-5-2600","article-title":"Osteoblastic cells are involved in osteoclast formation","volume":"123","author":"Takahashi","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib7","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1210\/endo.137.5.8612568","article-title":"Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact","volume":"137","author":"Jimi","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/bbrc.1997.6603","article-title":"Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis","volume":"234","author":"Tsuda","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib11","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1210\/en.139.3.1329","article-title":"Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG\/OCIF inhibits osteoclastogenesis in vitro","volume":"139","author":"Yasuda","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib12","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1006\/bbrc.1998.9294","article-title":"Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclast","volume":"250","author":"Akatsu","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0378-1119(98)00295-9","article-title":"Structure of the mouse osteoclastogenesis inhibitory factor (OCIF) gene and its expression in embryogenesis","volume":"215","author":"Mizuno","year":"1998","journal-title":"Gene"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/36593","article-title":"A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function","volume":"390","author":"Anderson","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib16","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1084\/jem.186.12.2075","article-title":"TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor","volume":"186","author":"Wong","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib17","doi-asserted-by":"crossref","first-page":"28355","DOI":"10.1074\/jbc.273.43.28355","article-title":"The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor","volume":"273","author":"Wong","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib18","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1073\/pnas.96.7.3540","article-title":"Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand","volume":"96","author":"Hsu","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib19","doi-asserted-by":"crossref","first-page":"6113","DOI":"10.4049\/jimmunol.161.11.6113","article-title":"A TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40","volume":"161","author":"Yun","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib20","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1096\/fasebj.12.10.845","article-title":"A new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption","volume":"12","author":"Kwon","year":"1998","journal-title":"FASEB J"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib21","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1074\/jbc.273.9.5117","article-title":"Characterization of structural domains of human osteoclastogenesis inhibitory factor","volume":"273","author":"Yamaguchi","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib22","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1210\/en.142.4.1419","article-title":"Determination of three isoforms of the receptor activator of nuclear factor-\u03baB lignad and their differential expression in bone and thymus","volume":"142","author":"Ikeda","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib23","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1172\/JCI13890","article-title":"Crystal structure of the TRANCE\/RANKL cytokine reveals determinants of receptor\u2013ligand specificity","volume":"108","author":"Lam","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib24","doi-asserted-by":"crossref","first-page":"13613","DOI":"10.1074\/jbc.274.19.13613","article-title":"Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival","volume":"274","author":"Lum","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib25","doi-asserted-by":"crossref","first-page":"20959","DOI":"10.1074\/jbc.C000290200","article-title":"Osteoprotegerin is an \u03b1v\u03b23-induced, NF-\u03baB-dependent survival factor for endothelial cells","volume":"275","author":"Malyankar","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib26","doi-asserted-by":"crossref","first-page":"20659","DOI":"10.1074\/jbc.M010153200","article-title":"Receptor activator of NF-kappa B and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis","volume":"276","author":"Collin-Osdoby","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib27","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/bbrc.2000.4130","article-title":"Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells","volume":"280","author":"Hofbauer","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib28","doi-asserted-by":"crossref","first-page":"46271","DOI":"10.1074\/jbc.M308545200","article-title":"Receptor activator of NF-\u03baB ligand (RANKL) induction via Jak2 and Stat5a in mammary epithelial cells","volume":"278","author":"Srivastava","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib29","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0301-472X(03)00233-9","article-title":"Expression of osteoprotegerin mRNA and protein in murine megakaryocytes","volume":"31","author":"Chagraoui","year":"2003","journal-title":"Exp Hematol"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib30","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S8756-3282(99)00214-8","article-title":"Localization of RANKL (receptor activator of NF-\u03baB ligand) mRNA and protein in skeletal and extraskeletal tissues","volume":"25","author":"Kartsogiannis","year":"1999","journal-title":"Bone"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib31","doi-asserted-by":"crossref","first-page":"26217","DOI":"10.1074\/jbc.M111093200","article-title":"Transforming growth factor-beta induces expression of receptor activator of NF-kappa B ligand in vascular endothelial cells derived from bone","volume":"277","author":"Ishida","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib32","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1006\/bbrc.1998.9788","article-title":"RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis","volume":"253","author":"Nakagawa","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib33","doi-asserted-by":"crossref","first-page":"39548","DOI":"10.1074\/jbc.M300539200","article-title":"Vascular endothelial growth factor up-regulates expression of receptor activator of NF-\u03baB (RANK) in endothelial cells: Concomitant increase of angiogenic responses to RANK ligand","volume":"278","author":"Min","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib34","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","article-title":"Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification","volume":"12","author":"Bucay","year":"1998","journal-title":"Gene Dev"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib35","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1084\/jem.192.4.463","article-title":"Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis","volume":"192","author":"Min","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib36","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/46303","article-title":"Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand","volume":"402","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0092-8674(00)00103-3","article-title":"The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development","volume":"103","author":"Fata","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib38","doi-asserted-by":"crossref","first-page":"30202","DOI":"10.1074\/jbc.M403968200","article-title":"A novel in vivo role for OPGL in activation of monocyte effector function and inflammatory response","volume":"279","author":"Seshasayee","year":"2004","journal-title":"J Biol Chem."},{"key":"10.1016\/j.cytogfr.2004.06.004_bib39","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1073\/pnas.97.4.1566","article-title":"RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism","volume":"97","author":"Li","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib40","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1101\/gad.13.8.1015","article-title":"TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling","volume":"13","author":"Lomaga","year":"1999","journal-title":"Genes Dev"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib41","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/nm1197-1285","article-title":"Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2","volume":"3","author":"Iotsova","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib42","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1359-6101(03)00027-3","article-title":"Biology of the TRANCE axis","volume":"14","author":"Walsh","year":"2003","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib43","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1006\/bbrc.1998.9394","article-title":"Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines","volume":"250","author":"Hofbauer","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib44","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1006\/bbrc.2000.2599","article-title":"The inhibitory effects of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide on osteoclast formation are associated with upregulation of osteoprotegerin and downregulation of RANKL and RANK","volume":"271","author":"Mukohyama","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib45","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1006\/bbrc.2000.4223","article-title":"Regulation of osteoprotegerin secretion from primary cultures of human bone marrow stromal cells","volume":"280","author":"Br\u00e4ndstr\u00f6m","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib46","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1210\/en.140.9.4367","article-title":"Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells","volume":"140","author":"Hofbauer","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib47","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1210\/en.142.6.2205","article-title":"17beta-estradiol stimulates expression of osteoprotegerin by a mouse stromal cell line, ST-2, via estrogen receptor-alpha","volume":"142","author":"Saika","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib48","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1210\/jc.2002-021877","article-title":"Raloxifene concurrently stimulates osteoprotegerin and inhibits interleukin-6 production by human trabecular osteoblasts","volume":"88","author":"Viereck","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib49","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1006\/bbrc.1998.9643","article-title":"Potential role of cbfa1, an essential transcriptional factor for osteoblast differentiation, in osteoclastogenesis: regulation of mRNA expression of osteoclast differentiation factor (ODF)","volume":"252","author":"Gao","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib50","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1210\/en.140.8.3552","article-title":"Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation","volume":"140","author":"Lee","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib51","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1210\/en.139.11.4743","article-title":"Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells","volume":"139","author":"Horwood","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib52","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1359\/JBMR.0301226","article-title":"PTH differentially regulates expression of RANKL and OPG","volume":"19","author":"Huang","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib53","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1210\/en.140.10.4451","article-title":"Breast cancer cells interact with osteoblasts to support osteoclast formation","volume":"140","author":"Thomas","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib54","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1210\/en.142.8.3656","article-title":"Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand","volume":"142","author":"Itoh","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib55","doi-asserted-by":"crossref","first-page":"10119","DOI":"10.1074\/jbc.M006918200","article-title":"Transcriptional mechanisms of bone morphogenetic protein-induced osteoprotegerin gene expression","volume":"276","author":"Wan","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib56","doi-asserted-by":"crossref","first-page":"36241","DOI":"10.1074\/jbc.M104319200","article-title":"Stimulation of osteoprotegerin (OPG) gene expression by transforming growth factor-beta (TGF-beta). Mapping of the OPG promoter region that mediates TGF-beta effects","volume":"276","author":"Thirunavukkarasu","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib57","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1210\/jc.2002-020656","article-title":"IGF-I regulates osteoprotegerin (OPG) and receptor activator of nuclear factor-kappaB ligand in vitro and OPG in vivo","volume":"87","author":"Rubin","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib58","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S8756-3282(03)00240-0","article-title":"Growth hormone substitution increases gene expression of members of the IGF family in cortical bone from women with adult onset growth homone deficiency-relationship with bone turn-over","volume":"33","author":"Ueland","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib59","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S8756-3282(99)00162-3","article-title":"Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells","volume":"25","author":"Hofbauer","year":"1999","journal-title":"Bone"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib60","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1006\/bbrc.2000.3379","article-title":"Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines","volume":"275","author":"Nakashima","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib61","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1074\/jbc.M104957200","article-title":"Interleukin-4 reversibly inhibits osteoclastogenesis via inhibition of NF-kappa B and mitogen-activated protein kinase signaling","volume":"277","author":"Wei","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib62","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1182\/blood-2002-11-3437","article-title":"IL-4 supresses both osteoclast development and mature osteoclast function by a STAT6-dependent mechanism: irreversible inhibition of the differentiation program activated by RANKL","volume":"102","author":"Moreno","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib63","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/1521-4141(200204)32:4<1090::AID-IMMU1090>3.0.CO;2-P","article-title":"Regulation of activation-induced receptor activator of NF-kappaB ligand (RANKL) expression in T cells","volume":"32","author":"Wang","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib64","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.4049\/jimmunol.169.6.3353","article-title":"IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae","volume":"169","author":"Palmqvist","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib65","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S8756-3282(03)00086-3","article-title":"Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease","volume":"33","author":"Bendre","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib66","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S8756-3282(02)00784-6","article-title":"Characterization of the bone-resorptive effect of interleukin-11 in cultured mouse calvarial bones","volume":"31","author":"Ahlen","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib67","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1006\/bbrc.2001.4380","article-title":"Interleukin-18 up-regulates osteoprotegerin expression in stromal\/osteoblastic cells","volume":"281","author":"Makiishi-Shimobayashi","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib68","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0014-5793(02)02872-7","article-title":"PDGF induces osteoprotegerin expression in vascular smooth muscle cells by multiple signal pathways","volume":"521","author":"Zhang","year":"2002","journal-title":"FEBS Lett"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib69","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1006\/bbrc.1998.9723","article-title":"Transforming growth factor-beta1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic\/stromal cells and inhibits the survival of murine osteoclast-like cells","volume":"252","author":"Murakami","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib70","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.4049\/jimmunol.165.8.4254","article-title":"Endogenous production of TGF-beta is essential for osteoclastogenesis induced by a combination of receptor activator of NF-kappa B ligand and macrophage-colony-stimulating factor","volume":"165","author":"Kaneda","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib71","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1359\/jbmr.2001.16.10.1787","article-title":"Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions","volume":"16","author":"Quinn","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib72","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S8756-3282(01)00420-3","article-title":"Tumor necrosis factor-alpha cooperates with receptor activator of nuclear factor kappaB ligand in generation of osteoclasts in stromal cell-depleted rat bone marrow cell culture","volume":"28","author":"Komine","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib73","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1074\/jbc.M008198200","article-title":"Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways","volume":"276","author":"Zhang","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib74","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1359\/jbmr.2001.16.11.2074","article-title":"Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand\/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors","volume":"16","author":"Chikazu","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib75","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1182\/blood.V97.11.3349","article-title":"Macrophage inflammatory protein-1alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand","volume":"97","author":"Han","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib76","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.4049\/jimmunol.166.5.3574","article-title":"Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors","volume":"166","author":"Kikuchi","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib77","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1046\/j.1365-2249.2002.01990.x","article-title":"LPS-stimulated human gingival fibroblasts inhibit the differentiation of monocytes into osteoclasts through the production of osteoprotegerin","volume":"130","author":"Nagasawa","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib78","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S8756-3282(02)00680-4","article-title":"Vector-averaged gravity regulates gene expression of receptor activator of NF-kappaB (RANK) ligand and osteoprotegerin in bone marrow stromal cells via cyclic AMP\/protein kinase A pathway","volume":"30","author":"Kanematsu","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib79","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1677\/joe.0.1590191","article-title":"Osteoprotegerin mRNA is expressed in primary human osteoblast-like cells: down-regulation by glucocorticoids","volume":"59","author":"Vidal","year":"1998","journal-title":"J Endocrinol"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib80","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1006\/bbrc.2000.4223","article-title":"Regulation of osteoprotegerin secretion from primary cultures of human bone marrow stromal cells","volume":"280","author":"Brandstrom","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib81","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1210\/en.141.12.4711","article-title":"Intracellular calcium and protein kinase C mediate expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in osteoblasts","volume":"141","author":"Takami","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib82","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/emm.2003.23","article-title":"High extracellular Ca2+ alone stimulates osteoclast formation but inhibits in the presence of other osteoclastogenic factors","volume":"35","author":"Shin","year":"2003","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib83","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1210\/en.2003-0319","article-title":"Osteoprotegerin expression and secretion is regulated by calcium influx through the L-type voltage-sensitive calcium channel","volume":"145","author":"Bergh","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib84","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/jcp.10270","article-title":"Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity","volume":"196","author":"Kanatami","year":"2003","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib85","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S8756-3282(00)00396-3","article-title":"Vitamin K(2) inhibits adipogenesis, osteoclastogenesis, and ODF\/RANK ligand expression in murine bone marrow cell cultures","volume":"27","author":"Takeuchi","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib86","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/jcb.10613","article-title":"Activin A stimulates IkappaB-alpha\/NF-kappaB and rank expression for osteoclast differentiation, but not AKT survival pathway in osteoclast precursors","volume":"90","author":"Sugatani","year":"2003","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib87","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0006-291X(02)02440-3","article-title":"Histamine stimulates production of osteoclast differentiation factor\/receptor activator of nuclear factor-kappaB ligand by osteoblasts","volume":"298","author":"Deyama","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib88","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1359\/jbmr.2002.17.7.1219","article-title":"Melatonin at pharmacologic doses increases bone mass by suppressing resorption through down-regulation of the RANKL-mediated osteoclast formation and activation","volume":"17","author":"Koyama","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib89","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0006-2952(00)00591-8","article-title":"Adrenergic stimulation of osteoclastogenesis mediated by expression of osteoclast differentiation factor in MC3T3-E1 osteoblast-like cells","volume":"61","author":"Takeuchi","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib90","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1359\/jbmr.2002.17.2.200","article-title":"Leptin inhibits osteoclast generation","volume":"17","author":"Holloway","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib91","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s00223-003-0033-5","article-title":"Triiodothyronine (T3) and 1,25-dihydroxyvitamin D3 (1,25D(3)) inversely regulate OPG gene expression in dependence of the osteoblastic phenotype","volume":"74","author":"Varga","year":"2004","journal-title":"Calcif Tissue Int."},{"key":"10.1016\/j.cytogfr.2004.06.004_bib92","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1172\/JCI10483","article-title":"Chronic alcohol ingestion induces osteoclastogenesis and bone loss through IL-6 in mice","volume":"106","author":"Dai","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib93","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0006-291X(02)00533-8","article-title":"Activation of peroxisome proliferator-activated receptor gamma inhibits osteoprotegerin gene expression in human aortic smooth muscle cells","volume":"294","author":"Fu","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib94","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1006\/bbrc.1999.0494","article-title":"Indian hedgehog in the late-phase differentiation in mouse chondrogenic EC cells, ATDC5: upregulation of type X collagen and osteoprotegerin ligand mRNAs","volume":"257","author":"Akiyama","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib95","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1006\/bbrc.2002.6510","article-title":"Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts","volume":"29","author":"Viereck","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib96","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1359\/jbmr.2004.19.1.147","article-title":"The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells activating TNF-\u03b1 converting enzyme (TACE)","volume":"19","author":"Pan","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib97","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1210\/en.2003-0726","article-title":"Nitric oxide regulates RANKL and OPG expression in bone marrow stromal cells","volume":"145","author":"Fan","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib98","doi-asserted-by":"crossref","first-page":"5752","DOI":"10.1074\/jbc.M311905200","article-title":"Gamma-glutamyl trasnpeptidase stimulates RANKL expression independent of its enzymatic activity and serves as a pathological bone-resorbing factor","volume":"279","author":"Niida","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib99","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bcp.2003.08.038","article-title":"Inhibition of osteoclast formation by 3-methylcholanthrene, a ligand for arylhydrocarbon receptor: suppression of osteoclast differentiation factor in osteogenic cells","volume":"l67","author":"Naruse","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib100","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1023\/A:1027362507683","article-title":"Bone marrow metastatic myeloma cells promote osteoclastogenesis through RANKL on endothelial cells","volume":"20","author":"Okada","year":"2003","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib101","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/1097-4652(200009)184:3<334::AID-JCP7>3.0.CO;2-U","article-title":"Activation of osteoclasts by interleukin-1: divergent responsiveness in osteoclasts formed in vivo and in vitro","volume":"184","author":"Fox","year":"2000","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib102","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1210\/en.143.3.1108","article-title":"TNFalpha potently activates osteoclasts, through a direct act independent of and strongly synergistic with RANKL","volume":"143","author":"Fuller","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib103","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/path.1190","article-title":"Proinflammatory cytokine (TNFalpha\/IL-1alpha) induction of human osteoclast formation","volume":"198","author":"Kudo","year":"2002","journal-title":"J Pathol"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib104","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/jcp.10041","article-title":"Lipopolysaccharide supports survival and fusion of preosteoclasts independent of TNF-alpha, IL-1, and RANKL","volume":"190","author":"Suda","year":"2002","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib105","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.cyto.2004.02.001","article-title":"Human interleukin-1-induced murine osteoclastogenesis is dependent on RANKL, but independent of TNF-a","volume":"26","author":"Ting","year":"2004","journal-title":"Cytokine"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib106","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bone.2003.08.008","article-title":"Transforming growth factor-\u03b2 induces osteoclast formation in the absence of RANKL","volume":"34","author":"Itonaga","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib107","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0014-5793(98)01731-1","article-title":"Receptor activator of NF-kappaB recruits multiple TRAF family adaptors and activates c-Jun N-terminal kinase","volume":"443","author":"Kim","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib108","doi-asserted-by":"crossref","first-page":"44347","DOI":"10.1074\/jbc.M202009200","article-title":"A RANK\/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function","volume":"277","author":"Armstrong","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib109","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2443.1999.00265.x","article-title":"Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice","volume":"4","author":"Naito","year":"1999","journal-title":"Genes Cells"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib110","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib111","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0006-291X(03)00695-8","article-title":"Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts","volume":"305","author":"Lee","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib112","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1210\/en.142.3.1290","article-title":"Receptor activator of nuclear factor-kappaB ligand activates nuclear factor-kappaB in osteoclast precursors","volume":"142","author":"Wei","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib113","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/nm1197-1285","article-title":"Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2","volume":"3","author":"Iotsova","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib114","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1359\/jbmr.2002.17.7.1200","article-title":"NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis","volume":"17","author":"Xing","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib115","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1359\/jbmr.2003.18.2.260","article-title":"Expression of either NF-kappaB p50 or p52 in osteoclast precursors is required for IL-1-induced bone resorption","volume":"18","author":"Xing","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib116","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1128\/MCB.22.4.992-1000.2002","article-title":"Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6","volume":"22","author":"Mizukami","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib117","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1242\/jcs.00082","article-title":"JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms","volume":"115","author":"David","year":"2002","journal-title":"J Cell Sci"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib118","doi-asserted-by":"crossref","first-page":"4999","DOI":"10.1210\/en.2003-0166","article-title":"p38 Mitogen-activated protein kinase is crucially involved in osteoclast differentiation but not in cytokine production, phagocytosis, or dendritic cell differentiation of bone marrow macrophages","volume":"144","author":"Li","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib119","doi-asserted-by":"crossref","first-page":"47366","DOI":"10.1074\/jbc.M208284200","article-title":"U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells","volume":"277","author":"Hotokezaka","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib120","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1126\/science.7939685","article-title":"c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling","volume":"266","author":"Grigoriadis","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib121","doi-asserted-by":"crossref","first-page":"11077","DOI":"10.1074\/jbc.M111696200","article-title":"Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NF-kappa B ligand signaling","volume":"277","author":"Mansky","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib122","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/jcb.10503","article-title":"Phosphatidylinositol 3-kinase coordinately activates the MEK\/ERK and AKT\/NFkappaB pathways to maintain osteoclast survival","volume":"89","author":"Gingery","year":"2003","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib123","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/sj.cdd.4401285","article-title":"M-CSF, TNFalpha and RANK ligand promote osteoclast survival by signaling through mTOR\/S6 kinase","volume":"10","author":"Glantschnig","year":"2003","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib124","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/35046196","article-title":"T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma","volume":"408","author":"Takayanagi","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib125","doi-asserted-by":"crossref","first-page":"27880","DOI":"10.1074\/jbc.M203836200","article-title":"Regulation of receptor activator of NF-\u03baB ligand-induced osteoclastogenesis by endogenous interferon-\u03b2 (IFN-\u03b2) and suppressor of cytokine signaling (SOCS)","volume":"277","author":"Hayashi","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib126","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/416744a","article-title":"RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta","volume":"416","author":"Takayanagi","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib127","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1186\/ar612","article-title":"Exposure to receptor-activator of NF-\u03baB ligand renders pre-osteoclasts resistant to IFN-\u03b3 by inducing terminal differentiation","volume":"5","author":"Huang","year":"2004","journal-title":"Arthritis Rheum Ther"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib128","doi-asserted-by":"crossref","first-page":"47217","DOI":"10.1074\/jbc.M304636200","article-title":"Multimerization of the RANKL isofoms and regulation of osteoclastogenesis","volume":"278","author":"Ikeda","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib129","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature02444","article-title":"Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis","volume":"428","author":"Koga","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib130","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0006-291X(02)00179-1","article-title":"Osteoprotegerin differentially regulates protease expression in osteoclast cultures","volume":"293","author":"Wittrant","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib131","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.bbrc.2003.09.084","article-title":"Regulation of osteoclast protease expression by RANKL","volume":"310","author":"Wittrant","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib132","first-page":"1","article-title":"Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-\u03baB ligand and osteoprotegerin biological activities","volume":"1644","author":"Wittrant","year":"2004","journal-title":"Exp Cell Res."},{"key":"10.1016\/j.cytogfr.2004.06.004_bib133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbamcr.2003.10.005","article-title":"Cellular activity and signaling induced by osteoprotegerin in osteoclasts: involvement of receptor activator of nuclear factor \u03baB ligand and MAPK","volume":"1644","author":"Th\u00e9oleyre","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib134","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1182\/blood-2002-04-1190","article-title":"Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells","volume":"100","author":"Standal","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib135","doi-asserted-by":"crossref","first-page":"14363","DOI":"10.1074\/jbc.273.23.14363","article-title":"Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL","volume":"273","author":"Emery","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib136","first-page":"1619","article-title":"Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells","volume":"62","author":"Holen","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib137","first-page":"912","article-title":"Osteoprotegerin is a soluble decoy receptor for tumor necrosis factor-related apoptosis-inducing ligand\/Apo2 ligand and can function as a paracrine survival factor for human myeloma cells","volume":"63","author":"Shipman","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib138","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI200317215","article-title":"Role of RANK ligand in mediating increased bone resorption in early postmenopausal women","volume":"111","author":"Eghbali-Fatourechi","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib139","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1530\/eje.0.1450199","article-title":"Serum parathyroid hormone, but not menopausal status, is associated with the expression of osteoprotegerin and RANKL mRNA in human bone samples","volume":"145","author":"Seck","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib140","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1359\/jbmr.1999.14.4.518","article-title":"Immunological characterization of circulating osteoprotegerin\/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis","volume":"14","author":"Yano","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib141","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1210\/jc.2002-020124","article-title":"Sequence variations in the osteoprotegerin gene promoter in patients with postmenopausal osteoporosis","volume":"87","author":"Arko","year":"2002","journal-title":"J Clin Endoc Metab"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib142","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1359\/jbmr.2002.17.7.1245","article-title":"Polymorphisms in the osteoprotegerin gene are associated with osteoporosis fractures","volume":"17","author":"Langdahl","year":"2002","journal-title":"J Bone Miner Rel Res"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib143","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S1096-7192(03)00125-2","article-title":"Association of polymorphisms of the osteoprotegerin gene with bone mineral density in Japanese women but not men","volume":"80","author":"Yamada","year":"2003","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib144","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1359\/jbmr.2001.16.2.348","article-title":"The effect of a single dose of osteoprotegerin in postmenopausal women","volume":"16","author":"Bekker","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib145","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/art.11487","article-title":"Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction","volume":"50","author":"Zwerina","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib146","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH672>3.0.CO;2-W","article-title":"Rheumatoid arthritis synovial macrophage-osteoclast differentiation is osteoprotegerin ligand-dependent","volume":"192","author":"Itonaga","year":"2000","journal-title":"J Pathol"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib147","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.4049\/jimmunol.170.5.2655","article-title":"IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand\/osteoprotegerin balance","volume":"170","author":"Lubberts","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib148","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/1529-0131(200004)43:4<821::AID-ANR12>3.0.CO;2-T","article-title":"Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis","volume":"43","author":"Romas","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib149","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W","article-title":"Involvement of receptor activator of nuclear factor kappaB ligand\/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis","volume":"43","author":"Takayanagi","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib150","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00418-001-0376-9","article-title":"RANK ligand, RANK, and OPG expression in type II collagen-induced arthritis mouse","volume":"117","author":"Mori","year":"2002","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib151","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0002-9440(10)63016-7","article-title":"TRANCE\/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis","volume":"159","author":"Pettit","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib152","doi-asserted-by":"crossref","first-page":"6019","DOI":"10.1128\/IAI.71.10.6019-6026.2003","article-title":"Streptococcus pyogenes infection induces septic arthritis with increased production of the receptor activator of the NF-kappaB ligand","volume":"71","author":"Sakurai","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib153","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0002-9440(10)64417-3","article-title":"Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis","volume":"161","author":"Romas","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib154","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1006\/mthe.2001.0245","article-title":"Adenoviral delivery of osteoprotegerin ameliorates bone resorption in a mouse ovariectomy model of osteoporosis","volume":"3","author":"Bolon","year":"2001","journal-title":"Mol Ther"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib155","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.2106\/00004623-200208000-00016","article-title":"Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis","volume":"84A","author":"Ulrich-Vinther","year":"2002","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib156","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1002\/art.10527","article-title":"Adeno-associated virus-mediated osteoprotegerin gene transfer protects against particulate polyethylene-induced osteolysis in a murine model","volume":"46","author":"Yang","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib157","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.1016\/S0142-9612(03)00384-3","article-title":"Distinct gene expression of receptor activator of nuclear factor-kappaB and rank ligand in the inflammatory response to variant morphologies of UHMWPE particles","volume":"24","author":"Ren","year":"2003","journal-title":"Biomaterials"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib158","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1302\/0301-620X.85B8.13311","article-title":"Imbalance of RANKL\/RANK\/OPG system in interface tissues in loosening of total hip replacement","volume":"85","author":"Mandelin","year":"2003","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib159","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0736-0266(02)00133-X","article-title":"RANKL is an essential cytokine mediator of polymethylmethacrylate particle-induced osteoclastogenesis","volume":"21","author":"Clohisy","year":"2003","journal-title":"J Orthop Res"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib160","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0142-9612(03)00556-8","article-title":"Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: expression of receptor activator NFkappa B, RANK ligand and osteoprotegerin","volume":"25","author":"Crotti","year":"2004","journal-title":"Biomaterials"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib161","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/71667","article-title":"Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis","volume":"24","author":"Hughes","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib162","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1359\/jbmr.2002.17.1.26","article-title":"Expansile skeletal hyperphosphatasia is caused by a 15-base pair tandem duplication in TNFRSF11A encoding RANK and is allelic to familial expansile osteolysis","volume":"17","author":"Whyte","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib163","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1359\/jbmr.2003.18.2.376","article-title":"Identification of a novel tandem duplication in exon 1 of the TNFRSF11A gene in two unrelated patients with familial expansile osteolysis","volume":"18","author":"Johnson-Pais","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib164","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1359\/jbmr.2003.18.8.1381","article-title":"Phenotypic characterization of early onset Paget's disease of bone caused by a 27-bp duplication in the TNFRSF11A gene","volume":"18","author":"Nakatsuka","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib165","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJMoa013096","article-title":"Osteoprotegerin deficiency and juvenile Paget's disease","volume":"347","author":"Whyte","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib166","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1056\/NEJM200211143472015","article-title":"Osteoprotegerin deficiency and juvenile Paget's disease","volume":"347","author":"Hofbauer","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib167","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1093\/hmg\/11.18.2119","article-title":"A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype","volume":"11","author":"Cundy","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib168","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1172\/JCI9133","article-title":"Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone","volume":"105","author":"Menaa","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib169","first-page":"17","article-title":"Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction","volume":"11","author":"Liu","year":"2003","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib170","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1359\/jbmr.2000.15.4.640","article-title":"Expression of osteoclast differentiation signals by stromal elements of giant cell tumors","volume":"15","author":"Atkins","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib171","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S8756-3282(01)00404-5","article-title":"Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of bone","volume":"28","author":"Atkins","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib172","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1309\/BPET-F2PE-P2BD-J3P3","article-title":"RANK (receptor activator of nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of bone","volume":"117","author":"Roux","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib173","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/mp.56.2.116","article-title":"Receptor activator of NF-kappaB ligand (RANKL) is expressed in chondroblastoma: possible involvement in osteoclastic giant cell recruitment","volume":"56","author":"Huang","year":"2003","journal-title":"Mol Pathol"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib174","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/S0002-9440(10)63560-2","article-title":"Receptor activator of nuclear factor \u03baB Ligand (RANKL)\/osteoprotegerin (OPG) ratio is increased in severe osteolysis","volume":"163","author":"Grimaud","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib175","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S8756-3282(02)00742-1","article-title":"Changes in osteoprotegerin and markers of bone metabolism during glucocorticoid treatment in patients with chronic glomerulonephritis","volume":"30","author":"Sasaki","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib176","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1093\/ndt\/17.2.233","article-title":"Serum osteoprotegerin and renal osteodystrophy","volume":"17","author":"Coen","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib177","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s00223-002-2100-8","article-title":"Osteoprotegerin levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism","volume":"73","author":"Stilgren","year":"2003","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib178","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1210\/en.2002-220602","article-title":"Double mutations in Klotho and osteoprotegerin gene loci rescued osteopetrotic phenotype","volume":"143","author":"Yamashita","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib179","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1530\/eje.0.1450685","article-title":"Increased serum osteoprotegerin in disorders characterized by persistent immune activation or glucorcorticoid excess-possible role in bone homeostasis","volume":"145","author":"Ueland","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib180","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1359\/jbmr.2003.18.5.852","article-title":"Sustained antiresorptive effects after a single treatment with human recombinant osteoprotegerin (OPG): a pharmacodynamic and pharmacokinetic analysis in rats","volume":"18","author":"Capparelli","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib181","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/109158180302200512","article-title":"A toxicity profile of osteoprotegerin in the cynomolgus monkey","volume":"22","author":"Smith","year":"2003","journal-title":"Int J Toxicol"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib182","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/S0041-1345(03)00755-3","article-title":"Osteoprotegerin and its correlations with new markers of bone formation and bone resorption in kidney transplant recipients","volume":"35","author":"Malyszko","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib183","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1210\/jc.2002-020775","article-title":"Increased osteoprotegerin serum levels in men with coronar artery disease","volume":"88","author":"Shoppet","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib184","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1161\/hq1001.097102","article-title":"Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D","volume":"21","author":"Price","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib185","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1210\/jc.86.2.631","article-title":"Association of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in erdely women","volume":"86","author":"Browner","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib186","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/01.CIR.0000031524.49139.29","article-title":"Serum ostoprotegerin levels are associated with the presence and severity of coronary artery disease","volume":"106","author":"Jono","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib187","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/01.CIR.0000127957.43874.BB","article-title":"Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease","volume":"109","author":"Kiechl","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib188","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1161\/hq1201.100229","article-title":"Differential expression of bone matrix regulatory proteins in human arterosclerotic plaques","volume":"21","author":"Dhore","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib189","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0006-291X(02)00137-7","article-title":"A single nucleotide polymorphism in the promoter region of the human gene for osteoprotegerin is related to vascular morphology and function","volume":"293","author":"Brandstrom","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib190","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.yjmcc.2003.09.015","article-title":"Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulate aortic valve calcification","volume":"36","author":"Kaden","year":"2004","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib191","first-page":"849","article-title":"Plasma osteoprotegerin as a biochemical maker for vascular dementia and Alzheimer's disease","volume":"13","author":"Emanuele","year":"2004","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib192","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1210\/jc.2002-021063","article-title":"Osteoprotegerin gene polymorphism and the risk of osteoporosis and vascular disease","volume":"87","author":"Hofbauer","year":"2002","journal-title":"J Clin Endoc Metab"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib193","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1006\/bbrc.2000.2182","article-title":"Age-related decline in osteoprotegerin expression by human bone marrow cells cultured in three-dimensional collagen sponges","volume":"268","author":"Makhluf","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib194","doi-asserted-by":"crossref","first-page":"212","DOI":"10.5435\/00124635-199407000-00004","article-title":"Wear debris in total joint replacements","volume":"2","author":"Jacobs","year":"1994","journal-title":"J Am Acad Orthop Surg"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib195","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/rheumatology\/keg047","article-title":"Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls","volume":"42","author":"Haynes","year":"2003","journal-title":"Rheumatology"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib196","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1182\/blood.V98.13.3534","article-title":"Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma","volume":"98","author":"Croucher","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib197","first-page":"287","article-title":"Recombinant osteoprotegerin decreases tumor burden and increases survival in a murine model of multiple myeloma","volume":"63","author":"Vanderkerken","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib198","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1182\/blood-2003-02-0380","article-title":"Soluble receptor activator of nuclear factor kappaB ligand\u2013osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index","volume":"102","author":"Terpos","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib199","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1182\/blood-2002-04-1121","article-title":"Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease","volume":"100","author":"Giuliani","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib200","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1182\/blood.V98.13.3527","article-title":"Myeloma cells induce imbalance in the osteoprotegerin\/osteoprotegerin ligand system in the human bone marrow environment","volume":"98","author":"Giuliani","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib201","doi-asserted-by":"crossref","first-page":"11581","DOI":"10.1073\/pnas.201394498","article-title":"Multiple myeloma disrupts the TRANCE\/osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression","volume":"98","author":"Pearse","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib202","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1046\/j.1365-2141.2002.03257.x","article-title":"Myeloma interacts with the bone marrow microenvironment to induce osteoclastogenesis and is dependent on osteoclast activity","volume":"116","author":"Yaccoby","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib203","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1046\/j.1365-2141.2002.03417.x","article-title":"RANK (receptor activator of nuclear factor-kappaB) and RANKL expression in multiple myeloma","volume":"117","author":"Roux","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib204","first-page":"5438","article-title":"Receptor activator of nuclear factor-kappaB ligand expression by human myeloma cells mediates osteoclast formation in vitro and correlates with bone destruction in vivo","volume":"63","author":"Farrugia","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib205","first-page":"912","article-title":"Osteoprotegerin is a soluble decoy receptor for tumor necrosis factor-related apoptosis-inducing ligand\/Apo2 ligand and can function as a paracrine survival factor for human myeloma cells","volume":"63","author":"Shipman","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib206","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cncr.11134","article-title":"RANK-Fc: a therapeutic antagonist for RANK-L in myeloma","volume":"97","author":"Sordillo","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib207","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/cncr.11138","article-title":"A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases","volume":"97","author":"Body","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib208","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/jso.10067","article-title":"Immunohistochemical study of receptor activator of nuclear factor kappa-B ligand (RANK-L) in human osteolytic bone tumors","volume":"79","author":"Good","year":"2002","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib209","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1136\/jcp.55.11.877","article-title":"Tumor cells produce receptor activator of NF-kappaB ligand (RANKL) in skeletal metastases","volume":"55","author":"Huang","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib210","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/path.1199","article-title":"RANK ligand is a prerequisite for cancer-associated osteolytic lesions","volume":"198","author":"Kitazawa","year":"2002","journal-title":"J Pathol"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib211","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/cncr.11127","article-title":"Bone markers in the management of patients with skeletal metastases","volume":"97","author":"Demers","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib212","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/jor.1100180617","article-title":"Osteoprotegerin inhibits tumor-induced osteoclastogenesis and bone tumor growth in osteopetrotic mice","volume":"18","author":"Clohisy","year":"2000","journal-title":"J Orthop Res"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib213","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S8756-3282(98)00141-0","article-title":"Osteoclastogenesis inhibitory factor exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy","volume":"23","author":"Akatsu","year":"1998","journal-title":"Bone"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib214","first-page":"783","article-title":"Osteoprotegerin prevents and reverses hypercalcemia in a murine model of humoral hypercalcemia of malignancy","volume":"60","author":"Capparelli","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib215","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/74999","article-title":"Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord","volume":"6","author":"Honore","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib216","first-page":"4038","article-title":"Osteoprotegerin diminishes advanced bone cancer pain","volume":"61","author":"Luger","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib217","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0090-4295(00)01122-5","article-title":"Osteoprotegerin and rank ligand expression in prostate cancer","volume":"57","author":"Brown","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib218","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1093\/clinchem\/47.11.2061","article-title":"Osteoprotegerin in serum as a novel marker of bone metastatic spread in prostate cancer","volume":"47","author":"Jung","year":"2001","journal-title":"Clin Chem"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib219","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1172\/JCI11685","article-title":"Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone","volume":"107","author":"Zhang","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib220","first-page":"1619","article-title":"Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells","volume":"62","author":"Holen","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib221","first-page":"2096","article-title":"Osteoprotegerin\/osteoclastogenesis inhibitory factor decreases human prostate cancer burden in human adult bone implanted into non obese diabetic\/severe combined immunodeficient mice","volume":"63","author":"Yonou","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib222","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1097\/01.ju.0000094191.39574.cb","article-title":"Serum osteoprotegerin and receptor activator of nuclear-factor kappa B ligand as indicators of disturbed osteoclastogenesis in patients with prostate cancer","volume":"170","author":"Jung","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib223","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1182\/blood.V99.2.634","article-title":"Mechanism of hypercalcemia in adult T-cell leukemia: overexpression of receptor activator of nuclear factor kappaB ligand on adult T-cell leukemia cells","volume":"99","author":"Nosaka","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib224","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1182\/blood.V98.9.2784","article-title":"Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines","volume":"98","author":"Fiumara","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib225","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1182\/blood-2002-11-3507","article-title":"MEK\/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival","volume":"102","author":"Zheng","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib226","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s00428-003-0845-8","article-title":"Expression of osteoprotegerin correlates with aggressiveness and poor prognosis of gastric carcinoma","volume":"443","author":"Ito","year":"2003","journal-title":"Virchows Arch"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib227","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/S0959-8049(03)00434-9","article-title":"Receptor activator of nuclear factor kappa B (RANK) is expressed as a late event during malignant progression in Barrett's metaplasia","volume":"39","author":"Yorke","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib228","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00401-003-0772-4","article-title":"Expression and functional activity of osteoprotegerin in human malignant gliomas","volume":"107","author":"Naumann","year":"2004","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib229","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1203\/01.pdr.0000127014.22068.15","article-title":"Osteoprotegerin in human milk: a potential role in the regulation of bone metabolism and immune development","volume":"55","author":"Vidal","year":"2004","journal-title":"Pediatr Res"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib230","first-page":"1637","article-title":"Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma","volume":"61","author":"Michigami","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib231","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1006\/bbrc.2000.2314","article-title":"Cancer cells responsible for humoral hypercalcemia express mRNA encoding a secreted form of ODF\/TRANCE that induces osteoclast formation","volume":"269","author":"Nagai","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib232","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1006\/bbrc.1999.2008","article-title":"Interactions between cancer and bone marrow cells induce osteoclast differentiation factor expression and osteoclast-like cell formation in vitro","volume":"267","author":"Chikatsu","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib233","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/01971520009349540","article-title":"Osteoclast differentiation factor in human osteosarcoma cell line","volume":"21","author":"Kinpara","year":"2000","journal-title":"J Immunoassay"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib234","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/art.10834","article-title":"Serum osteoprotegerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bisphosphonate","volume":"43","author":"Alvarez","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib235","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1359\/JBMR.040305","article-title":"A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in poostmenopausal women","volume":"19","author":"Bekker","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib236","first-page":"7883","article-title":"Soluble receptor activator of nuclear factor kappa B Fc diminishes prostate cancer progression in bone","volume":"63","author":"Zhang","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib237","doi-asserted-by":"crossref","first-page":"8269","DOI":"10.1074\/jbc.M309690200","article-title":"Disabling of RANK receptor complex by novel osteoprotegerin like peptidomimetics restores bone loss in vivo","volume":"279","author":"Cheng","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib238","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0736-0266(03)00156-6","article-title":"NF-\u03baB signaling blockade abolishes implant particle-induced osteoclastogenesis","volume":"22","author":"Clohisy","year":"2004","journal-title":"J Orthop Res"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib239","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1359\/jbmr.2002.17.2.192","article-title":"In vivo RANK signaling blockade using the receptor activator of NF-kappaB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis","volume":"17","author":"Childs","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib240","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.4049\/jimmunol.171.10.5547","article-title":"Direct inhibition of NF-kappa B Blocks bone erosion associated with inflammatory arthritis","volume":"171","author":"Clohisy","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2004.06.004_bib241","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S0006-2952(03)00470-2","article-title":"Decoy oligonucleotides targeting NF-\u03baB transcription factors: induction of apoptosis in human primary osteoclasts","volume":"66","author":"Penolazzi","year":"2003","journal-title":"Biochem Pharmacol"}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610104000747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610104000747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T12:54:19Z","timestamp":1682772859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610104000747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":241,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S1359610104000747"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2004.06.004","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}